Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
CAP
CAR
carmustine (BCNU)
castration-resistant prostate cancer (CRPC) Male Hormonal Therapies Question 10.2
CDA
CDK inhibitors antiapoptotic proteins cell cycle and transcription
CDKs
central nervous system (CNS) Answer 2.2 Answer 11.1 Anticancer Drug Development: An Introduction
cerebrospinal fluid (CSF) Anticancer Drug Development: An Introduction Transplant-Related Agents
cGVHD
checkpoint inhibitors (CPIs) immune-related adverse effects Multiple Myeloma as a Paradigm for Multi-Targeted Intervention anti-tumor immunity multiple cancers management
chimeric antigen receptor (CAR) Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors T-cell therapy Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
cHL
chronic graft-versus-host disease (cGVHD)
chronic lymphocytic leukemia (CLL) DNA Repair, Apoptotic Pathways, CDK Inhibitors Targeted Therapies (Small Molecules) Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase Question 3.1
CJD
cladribine, cytarabine, and filgrastim with mitoxantrone (CLAG-M) Question 3.7 Answer 3.2
classic Hodgkin's lymphoma (cHL)
CLL
Cmax
CMP
College of American Pathologists (CAP)
complement-dependent cytotoxicity (CDC)
complete remission (CR)
complete response(s) (CRs) Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
CAA
capillary leak syndrome (CLS)
cardiac repolarization (QTc)
CAR-T
CDC

NDX